| Filed On | Filing |
|---|---|
| 25 Nov 2024 | FORM 15 |
| 20 Nov 2024 | EFFECT |
| 15 Nov 2024 | 25-NSE |
| 15 Nov 2024 |
Form 4: snyderman nancy lynn Md, Director
Returned 14,944 shares to the issuer ($1.06M) · Disposed of 14,167 Stock Option (Right to Buy) (Disposition to Issuer) ($653K) |
| 15 Nov 2024 |
Form 4: Lopez Esteban, Director
Returned 6,600 shares to the issuer ($469K) · Disposed of 10,000 Stock Options (Right to buy) (Disposition to Issuer) ($113K) |
| 15 Nov 2024 |
Form 4: Kiernan Jane E, Director
Returned 19,861 shares to the issuer ($1.41M) |
| 15 Nov 2024 |
Form 4: Woock John, EVP, Chief Mktg/Strtgy Officer
Returned 77,403 shares to the issuer ($5.5M) · Disposed of 13,125 Performance-Based Restricted Stock Units (Disposition to Issuer) · Disposed of 19,136 Stock Options (Right to buy) (Disposition to Issuer) ($1.05M) |
| 15 Nov 2024 |
Form 4: Sama Rinda, Chief Operating Officer
Returned 84,462 shares to the issuer ($6M) · Disposed of 13,125 Performance-Based Restricted Stock Units (Disposition to Issuer) · Disposed of 20,981 Stock Options (Right to buy) (Disposition to Issuer) ($1.08M) · 1 more |
| 15 Nov 2024 |
Form 4: Noblett Karen, Chief Medical Officer
Returned 34,428 shares to the issuer ($2.44M) · Disposed of 7,500 Performance-Based Restricted Stock Units (Disposition to Issuer) · Disposed of 14,961 Stock Option (Right to Buy) (Disposition to Issuer) ($1M) · 1 more |
| 15 Nov 2024 |
Form 4: McNamara Robert, Director
Returned 14,861 shares to the issuer ($1.06M) · Disposed of 18,333 Stock Option (Right to Buy) (Disposition to Issuer) ($763K) |
| 15 Nov 2024 |
Form 4: Keese Kari Leigh, Chief Financial Officer
Returned 40,362 shares to the issuer ($2.87M) · Disposed of 3,125 Performance-Based Restricted Stock Units (Disposition to Issuer) |
| 15 Nov 2024 |
Form 4: Ford Alfred J Jr, Chief Commercial Officer
Returned 43,450 shares to the issuer ($3.08M) · Disposed of 11,250 Performance-Based Restricted Stock Units (Disposition to Issuer) · Disposed of 4,655 Stock Option (Right to Buy) (Disposition to Issuer) ($210K) |
| 15 Nov 2024 |
Form 4: Demski David M, Director
Returned 9,542 shares to the issuer ($677K) · Disposed of 10,000 Stock Options (Right to buy) (Disposition to Issuer) ($193K) |
| 15 Nov 2024 |
Form 4: Cohen Raymond W, Director
Returned 292,731 shares to the issuer ($20.8M) · Disposed of 31,125 Performance-Based Restricted Stock Units (Disposition to Issuer) · Disposed of 303,227 Stock Option (Right to Buy) (Disposition to Issuer) ($18.6M) |
| 15 Nov 2024 |
Form 4: Carrel Michael H, Director
Returned 17,861 shares to the issuer ($1.27M) · Disposed of 15,000 Stock Option (Right to Buy) (Disposition to Issuer) ($686K) |
| 15 Nov 2024 | POS AM |
| 15 Nov 2024 | S-8 POS |
| 15 Nov 2024 | S-8 POS |
| 15 Nov 2024 |
8-K: Completion of Acquisition or Disposition of Assets; Notice of Delisting or Failure to Satisfy a Listing Rule +4 more
Section 1. ANNUAL MEETING. The annual meeting of the stockholders of Axonics, Inc. (the “Corporation”), for the purpose of electing directors and for the transaction of such other business as may be brought before the meeting, shall be h... |
| 12 Nov 2024 |
Form 4: snyderman nancy lynn Md, Director
Gave 5,000 shares as a gift |
Loading...